Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Chegg, Inc. (CHGG) - free report >>
Minerva Neurosciences, Inc (NERV) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chegg, Inc. (CHGG) - free report >>
Minerva Neurosciences, Inc (NERV) - free report >>
Image: Bigstock
New Strong Buy Stocks for May 8th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Acacia Communications, Inc. : This company that develops, manufactures, and sells high-speed coherent optical interconnect products has seen the Zacks Consensus Estimate for its current year earnings increasing 18.7% over the last 60 days.
Acacia Communications Inc Price and Consensus
Acacia Communications Inc price-consensus-chart | Acacia Communications Inc Quote
NeuBase Therapeutics, Inc. (NBSE - Free Report) : This pre-clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 32.1% over the last 60 days.
NeuBase Pharmaceuticals Inc Price and Consensus
NeuBase Pharmaceuticals Inc price-consensus-chart | NeuBase Pharmaceuticals Inc Quote
Chegg, Inc. (CHGG - Free Report) : This company that operates direct-to-student learning platform has seen the Zacks Consensus Estimate for its current year earnings increasing 12% over the last 60 days.
Chegg Inc Price and Consensus
Chegg Inc price-consensus-chart | Chegg Inc Quote
Gossamer Bio, Inc. (GOSS - Free Report) : This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 2.1% over the last 60 days.
Gossamer Bio Inc Price and Consensus
Gossamer Bio Inc price-consensus-chart | Gossamer Bio Inc Quote
Minerva Neurosciences, Inc. (NERV - Free Report) : This company that focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases has seen the Zacks Consensus Estimate for its current year earnings increasing 9% over the last 60 days.
Minerva Neurosciences Inc Price and Consensus
Minerva Neurosciences Inc price-consensus-chart | Minerva Neurosciences Inc Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>